Jeil Pharm (002620) — Free Cash Flow Generation Index
Jeil Pharm (002620) has a Free Cash Flow Generation Index of -2.85x as of March 2026. Free cash flow of ₩-1.27 Billion represents -3% of operating cash flow (₩447.08 Million). Explore capital reinvestment ratio of Jeil Pharm to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Jeil Pharm Free Cash Flow Generation Index (2011–2025)
Historical FCF Generation Index trend for Jeil Pharm across 8 annual periods. For the full cash flow conversion analysis, see 002620 cash flow metrics.
Annual Free Cash Flow Generation for Jeil Pharm (2011–2025)
Year-by-year Free Cash Flow Generation Index for Jeil Pharm. Check Jeil Pharm investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | -22.90x | ₩-8.94 Billion | ₩390.26 Million | ₩9.33 Billion | ▼ -4382.3% |
| 2024 | -0.51x | ₩-2.32 Billion | ₩4.54 Billion | ₩6.86 Billion | ▲ +33.7% |
| 2021 | -0.77x | ₩-10.33 Billion | ₩13.40 Billion | ₩23.69 Billion | ▼ -182.5% |
| 2019 | 0.93x | ₩23.56 Billion | ₩25.22 Billion | ₩37.69 Billion | ▲ +87.5% |
| 2017 | 0.50x | ₩2.95 Billion | ₩5.92 Billion | ₩2.94 Billion | ▼ -86.4% |
| 2016 | 3.67x | ₩41.68 Billion | ₩11.36 Billion | ₩30.33 Billion | ▲ +6.2% |
| 2015 | 3.46x | ₩9.48 Billion | ₩2.74 Billion | ₩6.74 Billion | ▲ +77.5% |
| 2011 | 1.95x | ₩46.03 Billion | ₩23.63 Billion | ₩22.40 Billion | — |